Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa

MeSH terms

• Aminoglycosides
• Anti-Bacterial Agents / therapeutic use
• Bacteremia* / drug therapy
• Cephalosporins / therapeutic use
• Cross Infection* / drug therapy
• Healthcare-Associated Pneumonia*
• Humans
• Pharmaceutical Preparations*
• Polymyxins
• Pseudomonas aeruginosa
• Tazobactam / therapeutic use
• Treatment Outcome